• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高效液相色谱-荧光检测法测定,苯酚和对甲酚在尿毒症血清中蓄积。

Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.

作者信息

Niwa T

机构信息

Department of Clinical Laboratory, Nagoya University Branch Hospital, Japan.

出版信息

Clin Chem. 1993 Jan;39(1):108-11.

PMID:8419031
Abstract

We developed a simple and sensitive high-performance liquid chromatographic (HPLC) method that uses fluorescence as a detector for quantifying serum phenol and p-cresol in uremic patients on hemodialysis. Identification of phenol and p-cresol was confirmed by liquid chromatography/mass spectrometry. Because the HPLC method requires only simple extraction by ethyl acetate and does not require further steps such as derivatization, it is simple and rapid compared with gas chromatography or gas chromatography/mass spectrometry. Concentrations of phenol and p-cresol in uremic serum were significantly (p < 0.01) higher than those in normal serum. Reduction rates of phenol and p-cresol by hemodialysis were lower than those of urea and creatinine, suggesting a protein-binding property of phenol and p-cresol. This method will be useful for monitoring serum phenols in dialyzed patients as an index of hemodialysis adequacy.

摘要

我们开发了一种简单且灵敏的高效液相色谱(HPLC)方法,该方法使用荧光作为检测器来定量血液透析的尿毒症患者血清中的苯酚和对甲酚。通过液相色谱/质谱法确认了苯酚和对甲酚的鉴定。由于HPLC方法仅需要用乙酸乙酯进行简单提取,不需要衍生化等进一步步骤,与气相色谱或气相色谱/质谱法相比,它简单且快速。尿毒症血清中苯酚和对甲酚的浓度显著高于正常血清(p < 0.01)。血液透析对苯酚和对甲酚的清除率低于尿素和肌酐,表明苯酚和对甲酚具有蛋白结合特性。该方法将有助于监测透析患者的血清酚类,作为血液透析充分性的指标。

相似文献

1
Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.通过高效液相色谱-荧光检测法测定,苯酚和对甲酚在尿毒症血清中蓄积。
Clin Chem. 1993 Jan;39(1):108-11.
2
Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.口服吸附剂对实验性尿毒症大鼠血清中对甲酚蓄积的抑制作用。
Nephron. 1993;65(1):82-7. doi: 10.1159/000187446.
3
A gas chromatographic-mass spectrometric analysis for phenols in uremic serum.尿毒症血清中酚类物质的气相色谱-质谱分析
Clin Chim Acta. 1981 Feb 19;110(1):51-7. doi: 10.1016/0009-8981(81)90299-0.
4
A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure.一种用于定量慢性肾衰竭患者游离和总对甲酚的灵敏高效液相色谱法。
Clin Chim Acta. 1998 Nov;278(1):1-21. doi: 10.1016/s0009-8981(98)00124-7.
5
Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay.采用高效液相色谱法测定慢性肾脏病患者生物体液中的尿毒症溶质。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2281-6. doi: 10.1016/j.jchromb.2011.06.014. Epub 2011 Jun 15.
6
Simple high-performance liquid chromatographic analysis of phenol and p-cresol in urine and feces.尿液和粪便中苯酚和对甲酚的简单高效液相色谱分析
J Chromatogr B Biomed Appl. 1995 Dec 15;674(2):187-91. doi: 10.1016/0378-4347(95)00324-x.
7
Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.对接受血液透析的尿毒症患者口服乳酸菌制剂Lebenin后,其血液中尿毒症毒素及其粪便中前体物质的蓄积的抑制作用。
Nephron. 1996;74(2):349-55. doi: 10.1159/000189334.
8
HPLC study of uremic fluids related to optical dialysis adequacy monitoring.与光学透析充分性监测相关的尿毒症体液的高效液相色谱研究。
Int J Artif Organs. 2010 Feb;33(2):96-104.
9
Volatile phenols in serum of uraemic patients.尿毒症患者血清中的挥发性酚类物质。
Clin Sci. 1972 Oct;43(4):493-8. doi: 10.1042/cs0430493.
10
Fluorometric determination of phenol and p-cresol in urine by precolumn high-performance liquid chromatography using 4-(N-phthalimidinyl)benzenesulfonyl chloride.采用4-(N-邻苯二甲酰亚胺基)苯磺酰氯,通过柱前高效液相色谱法荧光测定尿液中的苯酚和对甲酚。
Anal Biochem. 1996 Dec 1;243(1):86-91. doi: 10.1006/abio.1996.0485.

引用本文的文献

1
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of -Cresol by Modulating Gut Microbiota in Mice.表没食子儿茶素-3-没食子酸酯通过调节小鼠肠道微生物群降低血浆和尿液中对甲酚的水平。
ACS Omega. 2022 Oct 28;7(44):40034-40041. doi: 10.1021/acsomega.2c04731. eCollection 2022 Nov 8.
2
The membrane perspective of uraemic toxins: which ones should, or can, be removed?尿毒症毒素的膜视角:哪些毒素应该或能够被清除?
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i17-i31. doi: 10.1093/ckj/sfab202. eCollection 2021 Dec.
3
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia.
肠道微生物群的异常代谢揭示了高尿酸血症诱发肾病的可能分子机制。
Acta Pharm Sin B. 2020 Feb;10(2):249-261. doi: 10.1016/j.apsb.2019.10.007. Epub 2019 Oct 30.
4
Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites.利用添加酪氨酸及其代谢产物的培养基来鉴定产苯酚和对甲酚的肠道细菌。
FEMS Microbiol Ecol. 2018 Sep 1;94(9). doi: 10.1093/femsec/fiy125.
5
Role of Gut-derived Uremic Toxins on Oxidative Stress and Inflammation in Patients with Chronic Kidney Disease.肠道源性尿毒症毒素在慢性肾脏病患者氧化应激和炎症中的作用
Indian J Nephrol. 2017 Sep-Oct;27(5):359-364. doi: 10.4103/ijn.IJN_71_17.
6
Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.在血液透析患者中使用口服活性炭吸附剂AST-120持续降低蛋白结合尿毒症毒素并改善氧化应激。
Sci Rep. 2015 Sep 23;5:14381. doi: 10.1038/srep14381.
7
Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.补充膳食纤维可降低慢性肾脏病患者血浆对甲酚水平。
J Ren Nutr. 2015 May;25(3):316-20. doi: 10.1053/j.jrn.2014.09.002. Epub 2014 Nov 5.
8
Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy Adult Women.连续摄入含有短双歧杆菌 Yakult 菌株和半乳寡糖的发酵乳有益于健康成年女性的皮肤状况。
Biosci Microbiota Food Health. 2013;32(1):33-9. doi: 10.12938/bmfh.32.33. Epub 2013 Jan 31.
9
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.终末期肾病中含脲酶和尿酸酶、产生吲哚和对甲酚的肠道微生物群的扩张以及产生短链脂肪酸的肠道微生物群的收缩。
Am J Nephrol. 2014;39(3):230-237. doi: 10.1159/000360010. Epub 2014 Mar 8.
10
Protein-bound uremic toxins: new insight from clinical studies.蛋白结合型尿毒症毒素:来自临床研究的新见解。
Toxins (Basel). 2011 Jul;3(7):911-9. doi: 10.3390/toxins3070911. Epub 2011 Jul 20.